JPMorgan Chase & Co’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$433K Sell
35,143
-1,094
-3% -$13.5K ﹤0.01% 4130
2025
Q1
$223K Sell
36,237
-236,981
-87% -$1.46M ﹤0.01% 4397
2024
Q4
$2.21M Buy
273,218
+79,110
+41% +$641K ﹤0.01% 3331
2024
Q3
$1.57M Buy
194,108
+169,397
+686% +$1.37M ﹤0.01% 3407
2024
Q2
$107K Buy
24,711
+2,467
+11% +$10.7K ﹤0.01% 4567
2024
Q1
$94.3K Sell
22,244
-15,481
-41% -$65.6K ﹤0.01% 4755
2023
Q4
$142K Buy
37,725
+3,156
+9% +$11.9K ﹤0.01% 4618
2023
Q3
$128K Sell
34,569
-24,109
-41% -$89.2K ﹤0.01% 4475
2023
Q2
$233K Buy
58,678
+58,483
+29,991% +$232K ﹤0.01% 4198
2023
Q1
$1K Hold
195
﹤0.01% 5636
2022
Q4
$1K Sell
195
-21,388
-99% -$110K ﹤0.01% 5434
2022
Q3
$62K Sell
21,583
-57,290
-73% -$165K ﹤0.01% 4631
2022
Q2
$317K Buy
78,873
+38,431
+95% +$154K ﹤0.01% 4106
2022
Q1
$221K Buy
40,442
+1,968
+5% +$10.8K ﹤0.01% 4392
2021
Q4
$175K Buy
38,474
+11,390
+42% +$51.8K ﹤0.01% 4601
2021
Q3
$126K Sell
27,084
-23,359
-46% -$109K ﹤0.01% 4609
2021
Q2
$346K Sell
50,443
-7,903
-14% -$54.2K ﹤0.01% 4203
2021
Q1
$583K Sell
58,346
-27,373
-32% -$274K ﹤0.01% 3961
2020
Q4
$636K Buy
85,719
+56,897
+197% +$422K ﹤0.01% 3623
2020
Q3
$170K Buy
28,822
+14,858
+106% +$87.6K ﹤0.01% 3803
2020
Q2
$88K Buy
13,964
+5,799
+71% +$36.5K ﹤0.01% 4006
2020
Q1
$29K Sell
8,165
-18,711
-70% -$66.5K ﹤0.01% 4276
2019
Q4
$195K Buy
26,876
+19,150
+248% +$139K ﹤0.01% 3818
2019
Q3
$49K Buy
7,726
+1,253
+19% +$7.95K ﹤0.01% 4262
2019
Q2
$49K Buy
+6,473
New +$49K ﹤0.01% 4257
2016
Q3
Sell
-2,941
Closed -$29K 4106
2016
Q2
$29K Buy
+2,941
New +$29K ﹤0.01% 3647